National Comprehensive Cancer Network



About NCCN

Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel - Disclosures as of 6/17/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Wallace Akerley, MD

None

Genentech, Inc.

None

None

3/5/2013

Hossein Borghaei, DO, MS

None

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.

None

None

7/2/2012

Andrew C. Chang, MD

None

None

None

None

5/15/2013

Richard T. Cheney, MD

None

None

None

None

7/3/2012

Lucian R. Chirieac, MD

None

None

None

None

5/1/2012

Thomas A. D'Amico, MD

None

Covidien AG;
Scanlan

None

None

2/28/2013

Todd L. Demmy, MD

None

None

None

None

10/12/2012

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Biodesix

None

None

2/28/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Apar Kishor P. Ganti, MD

Pfizer Inc.

None

None

None

3/27/2012

Ramaswamy Govindan, MD

None

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
GlaxoSmithKline

None

None

3/28/2012

Frederic W. Grannis, MD

None

Steven Phillips (sphillips@lpklaw.com)

None

None

6/18/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Leora Horn, MD, MSc, FRCPC

None

None

None

None

8/16/2012

Miranda Hughes, PhD

None

None

None

None

4/10/2013

Thierry M. Jahan, MD

None

Poniard Pharmaceuticals

None

None

4/16/2013

Mohammad Jahanzeb, MD, FACP

None

Genentech, Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

3/1/2012

Anne Kessinger, MD

Pharmacyclics;
sanofi-aventis U.S.

None

None

None

5/4/2011

Ritsuko Komaki, MD

Pfizer Inc.

None

None

None

7/3/2012

Feng-Ming (Spring) Kong, MD, PhD

None

None

None

None

10/9/2012

Mark G. Kris, MD

None

Boehringer Ingelheim GmbH;
Covidien AG;
National Cancer Institute;
Chugai Pharmaceuticals;
Clovis Oncology;
Pfizer Inc.

None

None

3/4/2013

Lee M. Krug, MD

Eli Lilly and Company;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
CanBas

Genentech, Inc.;
Morphotek Inc.

None

None

6/18/2012

Inga T. Lennes, MD

None

None

None

None

6/18/2012

Billy W. Loo, MD, PhD

None

General Electric;
Varian Medical Systems, Inc.

None

None

3/20/2013

Renato Martins, MD, MPH

None

Eli Lilly and Company;
Genentech, Inc.

None

None

4/8/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Janis O'Malley, MD

None

None

None

None

4/13/2011

Raymond U. Osarogiagbon, MD, FACP

Bristol-Myers Squibb Company;
Eli Lilly and Company

Genentech, Inc.;
OSI Pharmaceuticals, Inc.

None

None

6/15/2011

Gregory A. Otterson, MD

None

Abraxis Bioscience, Inc.;
Genentech, Inc.

None

None

1/23/2013

Jyoti D. Patel, MD

Eli Lilly and Company

Genentech, Inc.

None

None

3/26/2012

Mary C. Pinder-Schenck, MD

None

None

None

None

7/3/2012

Katherine M. Pisters, MD

None

None

None

None

4/10/2013

Karen Reckamp, MD, MS

None

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Response Genetics;
Tragara Pharmaceuticals

None

None

3/5/2013

Gregory J. Riely, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Chugai;
Tragara

None

None

8/16/2012

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

Scott Swanson, MD

None

Covidien AG;
Ethicon, Inc.

None

None

7/5/2012

Douglas E. Wood, MD

None

None

None

None

5/11/2013

Stephen C. Yang, MD

None

None

None

None

6/18/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved